Biodegradable prostate stent for BPH obstruction.
BiPS is a biodegradable prostate stent concept designed to maintain urethral patency during a therapy window and avoid a separate removal procedure.
Patent application under process IIT Roorkee material development
BPH problem and unmet need
BPH-related obstruction affects ageing men globally and current treatment options can be invasive, expensive or require ongoing management.
Surgery burden
TURP and laser procedures require procedural infrastructure and can carry recovery burden.
Permanent stent limitations
Migration, encrustation and removal concerns limit long-term acceptance.
Catheter dependency
Chronic catheter use increases infection risk and reduces dignity.
Unaddressed segment
The deck notes the non-surgical prostate stent market is yet to be fully addressed.
BiPS number from deck
The latest Gomida deck positions BiPS as an in-house manufactured product for urology and oncology clinics.
4,500 units
Expected sales by 2030 from the latest attached deck.
Sole manufacturer
Deck manufacturing plan: in-house production and supply.
Clinical evaluation
Roadmap includes clinical evaluation of BiPS after final material and prototype development.
CURRENT BPH OPTIONS VS BIPS
Same goal of restoring urinary flow. A biodegradable stent concept designed to avoid long-term implant burden.
Invasive or persistent device burden
- Metallic stents can create removal, encrustation or migration concerns.
- Surgical approaches may require operating-room infrastructure and recovery time.
- Prolonged catheterisation can increase infection risk and reduce comfort.
- Many patients still need a less invasive, time-limited pathway.
Temporary support designed to degrade
- Designed to maintain urethral patency during the therapy window.
- Biodegradable concept aims to avoid a separate removal procedure.
- Minimally invasive pathway for BPH obstruction management.
- Material development and clinical evaluation pathway highlighted in the deck.
Patent & clinical evidence
Dedicated space for validation, publications and clinical-evaluation updates.
Patent status
Patent application under process. Biodegradable material development at IIT Roorkee highlighted in the deck.
Clinical evidence space
Reserve this area for: degradation profile, biocompatibility, stent patency, patient outcomes, clinical evaluation reports and regulatory submissions.